Across TCGA pan-cancer cohorts, MIR3689A RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR3689A data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher MIR3689A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3689A expression acts as an unfavorable survival marker.
BRCA are the cancer types where MIR3689A RNA most reproducibly stratifies survival.